Document Detail


Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial.
MedLine Citation:
PMID:  2405964     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Bleeding in coronary artery bypass procedures increases morbidity and exposes patients to the risks associated with blood transfusion. Desmopressin acetate (DDAVP), a synthetic vasopressin analogue, may limit bleeding during cardiac surgery. In a prospective randomized trial, the authors evaluated the ability of DDAVP to reduce perioperative bleeding during uncomplicated coronary bypass operations. Sixty-two patients who underwent coronary artery bypass grafting were randomized to receive intraoperatively either a placebo or DDAVP. Both groups were similar with respect to operative characteristics and preoperative hematologic profiles, von Willebrand factor levels increased postoperatively in both placebo (2.77 +/- 1.06 versus 2.17 +/- 1.51 U) and DDAVP groups (2.75 +/- 0.94 versus 1.80 +/- 0.88 U). Only the increase in the DDAVP groups was significant (p less than 0.001). There was no difference in total blood loss between the placebo (1826 +/- 849 ml) and DDAVP groups (1716 +/- 688 ml). Total red cell transfusions were similar in placebo (3.4 +/- 1.3 units of blood) and DDAVP groups (3.6 +/- 0.8 units). These results do not support the intraoperative use of DDAVP to reduce perioperative bleeding in routine coronary artery bypass surgery.
Authors:
G S Hedderich; D J Petsikas; B A Cooper; M Leznoff; A J Guerraty; N L Poirier; J F Symes; J E Morin
Related Documents :
19575814 - The impact of avoiding cardiopulmonary by-pass during coronary artery bypass surgery in...
2378524 - Cardiopulmonary bypass for resection of low tracheal haemangioma.
1527144 - A prospective comparison of ankle/brachial indices and color duplex imaging in surveill...
2624804 - Internal mammary artery bypass: effect on longevity and recurrent angina pectoris in 29...
20132494 - Ablation of left ventricular tachycardia via transeptal approach and crossing of a mech...
2791694 - Myxoma with a left-to-left shunt and fistula.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Canadian journal of surgery. Journal canadien de chirurgie     Volume:  33     ISSN:  0008-428X     ISO Abbreviation:  Can J Surg     Publication Date:  1990 Feb 
Date Detail:
Created Date:  1990-03-20     Completed Date:  1990-03-20     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0372715     Medline TA:  Can J Surg     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  33-6     Citation Subset:  IM    
Affiliation:
Cardiovascular & Thoracic Surgery Service, Division of Hematology Medical Oncology, Royal Victoria Hospital, McGill University, Montreal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Transfusion
Coronary Artery Bypass*
Deamino Arginine Vasopressin / therapeutic use*
Female
Hemorrhage / blood,  prevention & control*
Humans
Male
Middle Aged
Platelet Count / drug effects
Postoperative Complications / prevention & control*
Prospective Studies
Randomized Controlled Trials as Topic
von Willebrand Factor / analysis,  drug effects
Chemical
Reg. No./Substance:
0/von Willebrand Factor; 16679-58-6/Deamino Arginine Vasopressin
Comments/Corrections
Comment In:
Can J Surg. 1990 Feb;33(1):5-6   [PMID:  2302601 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Authoring options for computer assisted nursing instruction.
Next Document:  Two heroes of the class of onety-seven: Part I.